BioMérieux ASEAN

14/05/2026

📢 Our 2025 Annual Report is now online!

This year’s milestones reflect our ongoing commitment to advance public health, innovation, and environmental responsibility.

From strengthening the global fight against AMR and sepsis to accelerating solutions that support more sustainable health systems, we continue working to deliver better outcomes for people, our communities, and the planet.

These achievements are possible thanks to the dedication of our ASEAN teams worldwide — united by the shared purpose of advancing diagnostics for a healthier future. 🩵

🔎 Discover our Annual Report and the work enhancing the future of global health: http://spkl.io/6042ANwxA

hashtag

12/05/2026

Some numbers are hard to process: according to the WHO, there were 282 million malaria cases and 610,000 deaths in 2024. And the most shocking of all: most of them were children under five years old. Behind these figures are families whose lives often depend on one thing: timely diagnosis - because when malaria is detected early, survival chances increase dramatically.

In our work at bioMérieux, we see on a daily basis how much diagnostics can change outcomes. Tools like the BIOFIRE® FILMARRAY® Tropical Fever Panel can identify the pathogens that cause malaria and other tropical diseases in about 50 minutes, which really helps clinicians act faster when it matters most. Malaria, after all, doesn't wait.

For us, it’s simple: giving healthcare professionals better tools means giving patients a better chance

👉 Learn more : http://spkl.io/6181Af2xJ

07/05/2026

Advancing the Fight Against AMR in the Philippines 🇵🇭

After nearly two years of collaboration, bioMérieux and St. Luke’s Medical Center – Global City (SLMC-GC) have officially signed the MOU for the Centre of Excellence in Antimicrobial Stewardship (April 29), with strong regional leadership support.

More than a milestone, this partnership reflects a shared commitment to tackling antimicrobial resistance (AMR)—one of the most pressing public health challenges today.

Together with SLMC-GC, we aim to strengthen stewardship practices, support clinical excellence, and drive meaningful, long-term impact in patient care and public health.

This is just the beginning. 🚀

05/05/2026

🎓✨ CME Highlights in Yangon!

On 22 April 2026, bioMérieux, together with Advanced Medical Diagnostics and Trading Co., Ltd., was delighted to support a CME session at Parami General Hospital 🇲🇲

👏 We heard valuable insights from:
Dr. U Tin Nyunt, Senior Consultant Pathologist and Director General (Retd.)
Dr. Daw Khin Myat New, Senior Consultant Microbiologist and Deputy Director of NHL (Retd.)
Wint Thu Naing (bioMérieux), on using local AMR data to guide safer antibiotic use in children

💬 With around 50 engaged healthcare professionals in attendance, the session sparked great discussions on AMR and antimicrobial stewardship (AMS).

Thank you to everyone for the energy, questions, and meaningful exchange! 👩‍⚕️🧑‍⚕️🌱

30/04/2026

🚀 We’re hiring across ASEAN!

Ready to grow your career with bioMérieux and make an impact in healthcare diagnostics?
Explore our latest opportunities:

🔬 PH Product Manager (Molecular)
👉 https://www.linkedin.com/jobs/view/4405070497/

📈 TH Sales Manager (Direct Channel)
👉 https://www.linkedin.com/jobs/view/4405071415/

🧪 PH Clinical Implementation Manager (North NCR / North Luzon)
👉 https://www.linkedin.com/jobs/view/4405076451/

📦 ASEAN East Supply Chain Manager
👉 https://www.linkedin.com/jobs/view/4405087169/

📄 TH Regulatory Affairs Specialist
👉 https://www.linkedin.com/jobs/view/4405072462/

✨ Join us in shaping the future of diagnostics.

👉 Learn more and apply via LinkedIn — feel free to like, share, or tag someone who’d be a great fit!

28/04/2026

We would like to CONGRATULATE bioMérieux Philippines on your brand‑new office! 🥳🎉

From humble beginnings to a bright, modern space with that stunning BGC skyline, what a milestone to celebrate!

This new home is a true reflection of your growth, teamwork, and all the hard work that brought you here.

The office may be new, but the heart, energy, and spirit of the PH team remain unmistakably the same💙

🏢✨ Cheers to new beginnings, new wins, and many great memories ahead. Congratulations, PH team — well deserved!

23/04/2026

When respiratory symptoms overlap, comprehensive results from point of care testing can eliminate send-out testing delays.

The BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panels deliver rapid, accurate answers for up to 15 respiratory viral and bacterial pathogens. With these panels, healthcare professionals have the potential to:

1. Inform Clinical Decisions: High sensitivity, specificity, and reliability provides results clinicians can trust. Testing for more than flu, RSV, and SARS-CoV-2 with one test provides healthcare professionals with a fuller picture.

2. Support Antimicrobial Stewardship: Comprehensive results in a clinically actionable timeframe may inform comprehensive diagnosis and optimize care and antimicrobial stewardship. Targeted, informed therapy can reduce the unnecessary prescription of antimicrobials.

3. Improve Patient Satisfaction: Using the right test, the first time, to detect multiple pathogens may result in reduced follow-up appointments, swabbing, and testing, which could improve patient comfort, experience, and convenience1.

4. Optimize Operations: The simple workflow and quick turnaround time enables rapid and comprehensive answers, which can be communicated to patients during the appointment, potentially reducing the need for callbacks or expensive and slow send-out testing.

16/04/2026

From joint infections and meningitis to community-acquired pneumonia, gastroenteritis, and sepsis, infectious diseases rarely follow a predictable path.

Across 5 clinical case studies, we showed how syndromic molecular testing can support decision-making when symptoms overlap, and time is of the essence. Each case offers a unique, real perspective on diagnostic challenges and the value of fast, actionable results in guiding appropriate patient care.

Catch up on any cases you may have missed, or rewatch the full series to learn how molecular testing can improve your patient outcomes:

- Joint infection: http://spkl.io/6183A2eYl
- Meningitis: http://spkl.io/6184A2eYm
- Sepsis: http://spkl.io/6185A2eYW
- Pneumonia: http://spkl.io/6186A2eYo
- Gastroenteritis: http://spkl.io/6187A2eYU

7 likes. "Joint Infection Clinical Case Study"

14/04/2026

⚖️ Meet Our Legal & Compliance Team
They help bioMérieux manage legal and compliance risks across ASEAN — enabling confident decisions and responsible business operations. 💙

10/04/2026

📢 ประกาศสำคัญสำหรับลูกค้ากลุ่ม Food Safety & Quality
เรียน ลูกค้าผู้มีอุปการะคุณทุกท่าน

bioMérieux ขอแจ้งให้ท่านทราบถึงการเปลี่ยนแปลงรูปแบบการจัดจำหน่ายผลิตภัณฑ์และบริการด้าน Food Safety & Quality (FSQ) ในประเทศไทย

🔹 ตั้งแต่วันที่ 27 มีนาคม 2569 เป็นต้นไป
DKSH Technology Limited จะสิ้นสุดบทบาทการเป็นผู้จัดจำหน่ายอย่างเป็นทางการ

✨ โดยการดูแลลูกค้าทั้งด้าน
• การขาย
• บริการลูกค้า
• การสนับสนุนทางเทคนิค

จะถูกโอนมายัง bioMérieux และพันธมิตรผู้จัดจำหน่ายที่ได้รับการแต่งตั้ง เพื่อยกระดับการให้บริการที่รวดเร็ว ใกล้ชิด และมีประสิทธิภาพยิ่งขึ้น

📌 ทีมงาน bioMérieux จะติดต่อท่านโดยตรง เพื่อแจ้งรายละเอียดผู้ดูแลอย่างเป็นทางการเร็ว ๆ นี้

🙏 เราขอขอบคุณทุกความไว้วางใจที่ผ่านมา และยืนยันความมุ่งมั่นในการส่งมอบบริการที่ดีที่สุดอย่างต่อเนื่อง

📞 ติดต่อเรา
📧 Email: [email protected]
Line ID:

📞 โทร: 02-661-5644

07/04/2026

🚚 Meet Our Supply Chain Team
They keep bioMérieux solutions moving across ASEAN — making sure our products reach the right customers at the right time. 💙